Nghe An Pharmaceutical Medical Material and Equipment Joint Stock Co
UUPCOM:NTF10,800.00
VND
-200.00
(-1.82%)
ISIN
VN000000NTF6
Return %
Stock
S&P 500
1Y
-53.04
14.20
3Y
-38.29
81.12
5Y
-73.46
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Address
- Vinh Vietnam
- Website
- dnapharma.com.vn
- Similar Companies
- Business
- Nghe An Pharmaceutical Medical Material and Equipment Joint Stock Company, operating commercially as DNA Pharma, is a Vietnam-based healthcare enterprise primarily engaged in the manufacturing, wholesale, retail, and distribution of pharmaceuticals, medical supplies, dietary supplements, and cosmetic products. The company operates across multiple core segments, including pharmaceutical manufacturing, medical equipment and consumable trading, and regional healthcare logistics. Its comprehensive product and service portfolio comprises solid and liquid dosage forms produced under World Health Organization Good Manufacturing Practice (WHO-GMP) standards; antibiotic and antifungal medications; analgesics, antipyretics, and anti-inflammatory formulations; vitamin and mineral health supplements, including Vitamin B-complex, Vitamin 3B, and Vitamin C DNA; gastrointestinal treatments and electrolyte rehydration products, including Oresol formulations; respiratory and central nervous system therapeutics; traditional herbal remedies; specialized medical apparatus, clinical instruments, and diagnostic supplies; personal care cosmetics; and certified pharmaceutical warehousing, quality testing, and supply chain distribution adhering to Good Storage Practice (GSP), Good Laboratory Practice (GLP), and Good Distribution Practice (GDP) standards. DNA Pharma serves institutional healthcare providers, including state and private hospitals, municipal clinics, and commercial pharmacy chains across Vietnam, while operating its own network of retail pharmacies, supply counters, and regional distribution agents centered in the North Central region. In recent major company developments, the company executed a significant capital expansion by successfully issuing 9,000,000 shares to increase its charter capital from VND 60 billion to VND 150 billion, deploying the raised capital primarily toward the construction of a new large-scale pharmaceutical manufacturing plant in the Bac Vinh Industrial Zone in Nghe An to modernize production infrastructure and expand output capacity, alongside augmenting its operating working capital. The company maintains close corporate ties within the BRG Group ecosystem through major institutional shareholdings held by entities including Ngan Anh Trading and Tourism Joint Stock Company and Thung Lung Vua Company Limited. Originally established on March 10, 1960, as a state-owned pharmaceutical enterprise and converted into a joint stock corporation in 2002, the company trades on the UPCoM exchange under the ticker NTF and is headquartered in Vinh City, Nghe An Province, Vietnam.